Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Glaxo Wellcome files application for new HIV protease inhibitor in Canada

Oct. 20, 1998

Ziagen to be reviewed by FDA advisory committee in early November

Oct. 20, 1998

Glaxo Wellcome submits NDA for new HIV protease inhibitor

Oct. 19, 1998

Promising results obtained with efavirenz in the treatment of pediatric HIV infection

Oct. 19, 1998

United Biomedical's B4 antibody holds promise for postexposure prophylaxis of HIV infection

Oct. 15, 1998

Fluoroquinolone derivative K-12 inhibits HIV in vitro

Oct. 14, 1998

Hughes Institute scientists recognized for breakthrough discovery in AIDS prevention

Oct. 9, 1998

Cel-Sci's AIDS vaccine demonstrates effectiveness in animal tests

Oct. 9, 1998

Ligand files new drug submission for Panretin Gel in Canada

Oct. 8, 1998

Emory University issued U.S. patent for FTC compound

Oct. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.